Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 11 November 1994:
Vol. 266. no. 5187, pp. 1042 - 1045
DOI: 10.1126/science.7973658
Prev | Table of Contents | Next

Articles

Science, Vol 266, Issue 5187, 1042-1045
Copyright © 1994 by American Association for the Advancement of Science

articles

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID

SM Russell, JA Johnston, M Noguchi, M Kawamura, CM Bacon, M Friedmann, M Berg, DW McVicar, BA Witthuhn, O Silvennoinen, and al. et

Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, Bethesda, MD 20892.

Interleukin-2 (IL-2) signaling requires the dimerization of the IL-2 receptor beta.(IL-2R beta) and common gamma (gamma c) chains. Mutations of gamma c can result in X-linked severe combined immunodeficiency (XSCID). IL-2, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3. Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations. Truncations of gamma c, and a gamma c, point mutation causing moderate X-linked combined immunodeficiency (XCID), decreased gamma c-Jak3 association. Thus, gamma c mutations in at least some XSCID and XCID patients prevent normal Jak3 activation, suggesting that mutations of Jak3 may result in an XSCID-like phenotype.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Novel Human Interleukin-15 Agonists.
X. Zhu, W. D. Marcus, W. Xu, H.-i. Lee, K. Han, J. O. Egan, J. L. Yovandich, P. R. Rhode, and H. C. Wong (2009)
J. Immunol. 183, 3598-3607
   Abstract »    Full Text »    PDF »
JAK3 Inhibition Significantly Attenuates Psoriasiform Skin Inflammation in CD18 Mutant PL/J Mice.
B. Y. Chang, F. Zhao, X. He, H. Ren, S. Braselmann, V. Taylor, J. Wicks, D. G. Payan, E. B. Grossbard, P. R. Pine, et al. (2009)
J. Immunol. 183, 2183-2192
   Abstract »    Full Text »    PDF »
Effect of CP-690,550, an Orally Active Janus Kinase Inhibitor, on Renal Function in Healthy Adult Volunteers.
N. Lawendy, S. Krishnaswami, R. Wang, D. Gruben, C. Cannon, S. Swan, and G. Chan (2009)
J. Clin. Pharmacol. 49, 423-429
   Abstract »    Full Text »    PDF »
Quantitative Proteomics Reveals GIMAP Family Proteins 1 and 4 to Be Differentially Regulated during Human T Helper Cell Differentiation.
J.-J. Filen, S. Filen, R. Moulder, S. Tuomela, H. Ahlfors, A. West, P. Kouvonen, S. Kantola, M. Bjorkman, M. Katajamaa, et al. (2009)
Mol. Cell. Proteomics 8, 32-44
   Abstract »    Full Text »    PDF »
IL-2 Receptor {beta}-Chain Signaling Controls Immunosuppressive CD4+ T Cells in the Draining Lymph Nodes and Lung during Allergic Airway Inflammation In Vivo.
A. Doganci, R. Karwot, J. H. Maxeiner, P. Scholtes, E. Schmitt, M. F. Neurath, H. A. Lehr, I-C. Ho, and S. Finotto (2008)
J. Immunol. 181, 1917-1926
   Abstract »    Full Text »    PDF »
Differential Regulation of the IL-17 Receptor by {gamma}c Cytokines: INHIBITORY SIGNALING BY THE PHOSPHATIDYLINOSITOL 3-KINASE PATHWAY.
M. J. Lindemann, Z. Hu, M. Benczik, K. D. Liu, and S. L. Gaffen (2008)
J. Biol. Chem. 283, 14100-14108
   Abstract »    Full Text »    PDF »
Phosphorylation of Human Jak3 at Tyrosines 904 and 939 Positively Regulates Its Activity.
H. Cheng, J. A. Ross, J. A. Frost, and R. A. Kirken (2008)
Mol. Cell. Biol. 28, 2271-2282
   Abstract »    Full Text »    PDF »
IL-4 Is a Critical Determinant in the Generation of Allergic Inflammation Initiated by a Constitutively Active Stat6.
S. Sehra, H. A. Bruns, A.-N. N. Ahyi, E. T. Nguyen, N. W. Schmidt, E. G. Michels, G.-U. von Bulow, and M. H. Kaplan (2008)
J. Immunol. 180, 3551-3559
   Abstract »    Full Text »    PDF »
Critical role for Rsk2 in T-lymphocyte activation.
J.-X. Lin, R. Spolski, and W. J. Leonard (2008)
Blood 111, 525-533
   Abstract »    Full Text »    PDF »
Regulation of interleukin-2 signaling by fatty acids in human lymphocytes.
R. Gorjao, S. M. Hirabara, T. M. de Lima, M. F. Cury-Boaventura, and R. Curi (2007)
J. Lipid Res. 48, 2009-2019
   Abstract »    Full Text »    PDF »
Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment.
C.-L. Hsu, K. Kikuchi, and M. Kondo (2007)
Blood 110, 1420-1428
   Abstract »    Full Text »    PDF »
Stat5 Is Essential for Early B Cell Development but Not for B Cell Maturation and Function.
X. Dai, Y. Chen, L. Di, A. Podd, G. Li, K. D. Bunting, L. Hennighausen, R. Wen, and D. Wang (2007)
J. Immunol. 179, 1068-1079
   Abstract »    Full Text »    PDF »
Immunostimulatory Effects of the Anionic Alkali Mineral Complex BARODON on Equine Lymphocytes.
H. Koo, S.-H. Ryu, H. J. Ahn, W. K. Jung, Y. K. Park, N. H. Kwon, S. H. Kim, J. M. Kim, B. W. Yoo, S. I. Choi, et al. (2006)
Clin. Vaccine Immunol. 13, 1255-1266
   Abstract »    Full Text »    PDF »
Binding of SH2-B Family Members within a Potential Negative Regulatory Region Maintains JAK2 in an Active State..
J. H. Kurzer, P. Saharinen, O. Silvennoinen, and C. Carter-Su (2006)
Mol. Cell. Biol. 26, 6381-6394
   Abstract »    Full Text »    PDF »
Constitutive Activation of STAT5 Supersedes the Requirement for Cytokine and TCR Engagement of CD4+ T Cells in Steady-State Homeostasis.
D. K. Taylor, P. T. Walsh, D. F. LaRosa, J. Zhang, M. A. Burchill, M. A. Farrar, and L. A. Turka (2006)
J. Immunol. 177, 2216-2223
   Abstract »    Full Text »    PDF »
Jak3 negatively regulates dendritic-cell cytokine production and survival.
K. Yamaoka, B. Min, Y.-J. Zhou, W. E. Paul, and J. J. O'Shea (2005)
Blood 106, 3227-3233
   Abstract »    Full Text »    PDF »
The Mannich Base NC1153 Promotes Long-Term Allograft Survival and Spares the Recipient from Multiple Toxicities.
S. M. Stepkowski, J. Kao, M.-E. Wang, N. Tejpal, H. Podder, L. Furian, J. Dimmock, A. Jha, U. Das, B. D. Kahan, et al. (2005)
J. Immunol. 175, 4236-4246
   Abstract »    Full Text »    PDF »
Interleukins 2 and 15 Regulate Ets1 Expression via ERK1/2 and MNK1 in Human Natural Killer Cells.
E. M. Grund, D. D. Spyropoulos, D. K. Watson, and R. C. Muise-Helmericks (2005)
J. Biol. Chem. 280, 4772-4778
   Abstract »    Full Text »    PDF »
Targeting the Jak/STAT pathway for immunosuppression.
J J O'Shea (2004)
Ann Rheum Dis 63, ii67-ii71
   Full Text »    PDF »
Different Costimulatory and Growth Factor Requirements for CD4+ and CD8+ T Cell-Mediated Rejection.
M. D. Vu, F. Amanullah, Y. Li, G. Demirci, M. H. Sayegh, and X. C. Li (2004)
J. Immunol. 173, 214-221
   Abstract »    Full Text »    PDF »
Jak3-Independent Trafficking of the Common {gamma} Chain Receptor Subunit: Chaperone Function of Jaks Revisited.
S. R. Hofmann, A. Q. Lam, S. Frank, Y.-J. Zhou, H. L. Ramos, Y. Kanno, D. Agnello, R. J. Youle, and J. J. O'Shea (2004)
Mol. Cell. Biol. 24, 5039-5049
   Abstract »    Full Text »    PDF »
The Molecular Pathology of Primary Immunodeficiencies.
M. S. Lim and K. S.J. Elenitoba-Johnson (2004)
J. Mol. Diagn. 6, 59-83
   Full Text »    PDF »
JAK3: not just another kinase.
W. Friedrich (2004)
Blood 103, 1978-1979
   Full Text »    PDF »
Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.
J. L. Roberts, A. Lengi, S. M. Brown, M. Chen, Y.-J. Zhou, J. J. O'Shea, and R. H. Buckley (2004)
Blood 103, 2009-2018
   Abstract »    Full Text »    PDF »
Identification of Protein Tyrosine Phosphatases with Specificity for the Ligand-Activated Growth Hormone Receptor.
C. Pasquali, M.-L. Curchod, S. Walchli, X. Espanel, M. Guerrier, F. Arigoni, G. Strous, and R. H. van Huijsduijnen (2003)
Mol. Endocrinol. 17, 2228-2239
   Abstract »    Full Text »    PDF »
Interleukin-7 Is a Direct Inhibitor of in Vitro Osteoclastogenesis.
S.-K. Lee, J. F. Kalinowski, S. L. Jastrzebski, L. Puddington, and J. A. Lorenzo (2003)
Endocrinology 144, 3524-3531
   Abstract »    Full Text »    PDF »
Interleukin-13 Induction of 15-Lipoxygenase Gene Expression Requires p38 Mitogen-Activated Protein Kinase-Mediated Serine 727 Phosphorylation of Stat1 and Stat3.
B. Xu, A. Bhattacharjee, B. Roy, H.-M. Xu, D. Anthony, D. A. Frank, G. M. Feldman, and M. K. Cathcart (2003)
Mol. Cell. Biol. 23, 3918-3928
   Abstract »    Full Text »    PDF »
Diaminobiotin and Desthiobiotin Have Biotin-Like Activities in Jurkat Cells.
R. Rodriguez-Melendez, B. Lewis, R. J. McMahon, and J. Zempleni (2003)
J. Nutr. 133, 1259-1264
   Abstract »    Full Text »    PDF »
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential.
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen (2003)
Pharmacol. Rev. 55, 133-166
   Abstract »    Full Text »    PDF »
Biotin Supplementation Increases Expression of Genes Encoding Interferon-{gamma}, Interleukin-1{beta}, and 3-Methylcrotonyl-CoA Carboxylase, and Decreases Expression of the Gene Encoding Interleukin-4 in Human Peripheral Blood Mononuclear Cells.
S. Wiedmann, J. D. Eudy, and J. Zempleni (2003)
J. Nutr. 133, 716-719
   Abstract »    Full Text »    PDF »
Interleukin-2 receptor-gamma -dependent endocytosis depends on biotin in Jurkat cells.
R. Rodriguez-Melendez, G. Camporeale, J. B. Griffin, and J. Zempleni (2003)
Am J Physiol Cell Physiol 284, C415-C421
   Abstract »    Full Text »    PDF »
Enforced Expression of Bcl-2 Restores the Number of NK Cells, But Does Not Rescue the Impaired Development of NKT Cells or Intraepithelial Lymphocytes, in IL-2/IL-15 Receptor {beta}-Chain-Deficient Mice.
M. Minagawa, H. Watanabe, C. Miyaji, K. Tomiyama, H. Shimura, A. Ito, M. Ito, J. Domen, I. L. Weissman, and K. Kawai (2002)
J. Immunol. 169, 4153-4160
   Abstract »    Full Text »    PDF »
IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells.
K. Liu, M. Catalfamo, Y. Li, P. A. Henkart, and N.-p. Weng (2002)
PNAS 99, 6192-6197
   Abstract »    Full Text »    PDF »
Specificity of Interleukin-2 Receptor gamma Chain Superfamily Cytokines Is Mediated by Insulin Receptor Substrate-dependent Pathway.
H. Xiao, T. Yin, X.-Y. Wang, T. Uchida, J. Chung, M. F. White, and Y.-C. Yang (2002)
J. Biol. Chem. 277, 8091-8098
   Abstract »    Full Text »    PDF »
SH2-B Family Members Differentially Regulate JAK Family Tyrosine Kinases.
K. B. O'Brien, J. J. O'Shea, and C. Carter-Su (2002)
J. Biol. Chem. 277, 8673-8681
   Abstract »    Full Text »    PDF »
Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor {alpha}.
D. Franchimont, J. Galon, M. S. Vacchio, S. Fan, R. Visconti, D. M. Frucht, V. Geenen, G. P. Chrousos, J. D. Ashwell, and J. J. O'Shea (2002)
J. Immunol. 168, 2212-2218
   Abstract »    Full Text »    PDF »
IL-2 and Related Cytokines Can Promote T Cell Survival by Activating AKT.
E. Kelly, A. Won, Y. Refaeli, and L. V. Parijs (2002)
J. Immunol. 168, 597-603
   Abstract »    Full Text »    PDF »
Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin.
S. M. Stepkowski, R. A. Erwin-Cohen, F. Behbod, M.-E. Wang, X. Qu, N. Tejpal, Z. S. Nagy, B. D. Kahan, and R. A. Kirken (2002)
Blood 99, 680-689
   Abstract »    Full Text »    PDF »
Role for lipid rafts in regulating interleukin-2 receptor signaling.
M. D. Marmor and M. Julius (2001)
Blood 98, 1489-1497
   Abstract »    Full Text »    PDF »
Cutting Edge: The Common {{gamma}}-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex.
H. Asao, C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster, and K. Sugamura (2001)
J. Immunol. 167, 1-5
   Abstract »    Full Text »    PDF »
Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.
E. D. White, R. P. Andrews, and G. K. K. Hershey (2001)
J. Leukoc. Biol. 69, 825-830
   Abstract »    Full Text »
Concomitant Inhibition of Janus Kinase 3 and Calcineurin-Dependent Signaling Pathways Synergistically Prolongs the Survival of Rat Heart Allografts.
F. Behbod, R. A. Erwin-Cohen, M.-E. Wang, B. W. Trawick, X. Qu, R. Verani, B. D. Kahan, S. M. Stepkowski, and R. A. Kirken (2001)
J. Immunol. 166, 3724-3732
   Abstract »    Full Text »    PDF »
A p74 common gamma receptor chain isoform facilitates IL-2 and IL-15 responses by the myelomonocytic cell line Tf-1{beta}2.
N. L. Monson, T. J. Fenske, S. Wei, A. J. Okragly, J. L.O. de Jong, M. Haak-Frendscho, J. O’Shea, J. Djeu, and P. M. Sondel (2001)
J. Leukoc. Biol. 69, 419-425
   Abstract »    Full Text »
Fes Mediates the IL-4 Activation of Insulin Receptor Substrate-2 and Cellular Proliferation.
H. Jiang, K. Foltenyi, M. Kashiwada, L. Donahue, B. Vuong, B. Hehn, and P. Rothman (2001)
J. Immunol. 166, 2627-2634
   Abstract »    Full Text »    PDF »
JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
B. Sporri, P. E. Kovanen, A. Sasaki, A. Yoshimura, and W. J. Leonard (2001)
Blood 97, 221-226
   Abstract »    Full Text »    PDF »
Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor {alpha} chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
R. Umeshita-Suyama, R. Sugimoto, M. Akaiwa, K. Arima, B. Yu, M. Wada, M. Kuwano, K. Nakajima, N. Hamasaki, and K. Izuhara (2000)
Int. Immunol. 12, 1499-1509
   Abstract »    Full Text »    PDF »
Lack of Phosphotyrosine Phosphatase SHP-1 Expression in Malignant T-Cell Lymphoma Cells Results from Methylation of the SHP-1 Promoter.
Q. Zhang, P. N. Raghunath, E. Vonderheid, N. Odum, and M. A. Wasik (2000)
Am. J. Pathol. 157, 1137-1146
   Abstract »    Full Text »    PDF »
Hierarchy of Protein Tyrosine Kinases in Interleukin-2 (IL-2) Signaling: Activation of Syk Depends on Jak3; However, Neither Syk nor Lck Is Required for IL-2-Mediated STAT Activation.
Y.-J. Zhou, K. S. Magnuson, T. P. Cheng, M. Gadina, D. M. Frucht, J. Galon, F. Candotti, R. L. Geahlen, P. S. Changelian, and J. J. O'Shea (2000)
Mol. Cell. Biol. 20, 4371-4380
   Abstract »    Full Text »
Bcl-3 Expression Promotes Cell Survival following Interleukin-4 Deprivation and Is Controlled by AP1 and AP1-Like Transcription Factors.
A. Rebollo, L. Dumoutier, J.-C. Renauld, A. Zaballos, V. Ayllón, and C. Martínez-A. (2000)
Mol. Cell. Biol. 20, 3407-3416
   Abstract »    Full Text »
IL-2 Signaling in Human Monocytes Involves the Phosphorylation and Activation of p59hck 1.
M. C. Bosco, R. E. Curiel, A. H. Zea, M. G. Malabarba, J. R. Ortaldo, and I. Espinoza-Delgado (2000)
J. Immunol. 164, 4575-4585
   Abstract »    Full Text »    PDF »
Interleukin-4 Mediates Cell Growth Inhibition through Activation of Stat1.
T. L.-Y. Chang, X. Peng, and X.-Y. Fu (2000)
J. Biol. Chem. 275, 10212-10217
   Abstract »    Full Text »    PDF »
The IL-2 Receptor Promotes Lymphocyte Proliferation and Induction of the c-myc, bcl-2, and bcl-x Genes Through the trans-Activation Domain of Stat5.
J. D. Lord, B. C. McIntosh, P. D. Greenberg, and B. H. Nelson (2000)
J. Immunol. 164, 2533-2541
   Abstract »    Full Text »    PDF »
Signals from the IL-9 Receptor Are Critical for the Early Stages of Human Intrathymic T Cell Development.
M. De Smedt, B. Verhasselt, T. Kerre, D. Vanhecke, E. Naessens, G. Leclercq, J.-C. Renauld, J. Van Snick, and J. Plum (2000)
J. Immunol. 164, 1761-1767
   Abstract »    Full Text »    PDF »
The First {alpha} Helix of Interleukin (Il)-2 Folds as a Homotetramer, Acts as an Agonist of the IL-2 Receptor {beta} Chain, and Induces Lymphokine-Activated Killer Cells.
R. Eckenberg, T. Rose, J.-L. Moreau, R. Weil, F. Gesbert, S. Dubois, D. Tello, M. Bossus, H. Gras, A. Tartar, et al. (2000)
J. Exp. Med. 191, 529-540
   Abstract »    Full Text »    PDF »
Complex Effects of Naturally Occurring Mutations in the JAK3 Pseudokinase Domain: Evidence for Interactions between the Kinase and Pseudokinase Domains.
M. Chen, A. Cheng, F. Candotti, Y.-J. Zhou, A. Hymel, A. Fasth, L. D. Notarangelo, and J. J. O'Shea (2000)
Mol. Cell. Biol. 20, 947-956
   Abstract »    Full Text »
IL-2 Unresponsiveness in Anergic CD4+ T Cells Is Due to Defective Signaling Through the Common {gamma}-Chain of the IL-2 Receptor.
S. Grundstrom, M. Dohlsten, and A. Sundstedt (2000)
J. Immunol. 164, 1175-1184
   Abstract »    Full Text »    PDF »
Blocking the Common {gamma}-Chain of Cytokine Receptors Induces T Cell Apoptosis and Long-Term Islet Allograft Survival.
X. C. Li, A. Ima, Y. Li, X. X. Zheng, T. R. Malek, and T. B. Strom (2000)
J. Immunol. 164, 1193-1199
   Abstract »    Full Text »    PDF »
FUNCTIONAL INTERLEUKIN 4 RECEPTOR AND INTERLEUKIN 2 RECEPTOR COMMON {gamma}-CHAIN ON HUMAN NON-SMALL CELL LUNG CANCERS: NOVEL TARGETS FOR IMMUNE THERAPY.
R. Essner, Y. Huynh, T. Nguyen, D. L. Morton, and D. S. B. Hoon (2000)
J. Thorac. Cardiovasc. Surg. 119, 10-20
   Abstract »    Full Text »    PDF »
Differential susceptibility of human Th1 versus T h 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells.
A. A. Vandenbark, D. Barnes, T. Finn, D. N. Bourdette, R. Whitham, I. Robey, J. Kaleeba, B. F. Bebo Jr, S. D. Miller, H. Offner, et al. (2000)
Int. Immunol. 12, 57-66
   Abstract »    Full Text »    PDF »
Prostaglandin E2 Selectively Inhibits Human CD4+ T Cells Secreting Low Amounts of Both IL-2 and IL-4.
X. He and J. M. Stuart (1999)
J. Immunol. 163, 6173-6179
   Abstract »    Full Text »    PDF »
Restoration of Lymphoid Populations in a Murine Model of X-Linked Severe Combined Immunodeficiency by a Gene-Therapy Approach.
M. Lo, M. L. Bloom, K. Imada, M. Berg, J. M. Bollenbacher, E. T. Bloom, B. L. Kelsall, and W. J. Leonard (1999)
Blood 94, 3027-3036
   Abstract »    Full Text »    PDF »
CIS Associates with the Interleukin-2 Receptor beta Chain and Inhibits Interleukin-2-dependent Signaling.
M. J. Aman, T.-S. Migone, A. Sasaki, D. P. Ascherman, M.-h. Zhu, E. Soldaini, K. Imada, A. Miyajima, A. Yoshimura, and W. J. Leonard (1999)
J. Biol. Chem. 274, 30266-30272
   Abstract »    Full Text »    PDF »
Reconstitution of Early Lymphoid Proliferation and Immune Function in Jak3-Deficient Mice by Interleukin-3.
M. P. Brown, T. Nosaka, R. A. Tripp, J. Brooks, J. M.A. van Deursen, M. K. Brenner, P. C. Doherty, and J. N. Ihle (1999)
Blood 94, 1906-1914
   Abstract »    Full Text »    PDF »
Distinct Roles for STAT1, STAT3, and STAT5 in Differentiation Gene Induction and Apoptosis Inhibition by Interleukin-9.
J.-B. Demoulin, E. Van Roost, M. Stevens, B. Groner, and J.-C. Renauld (1999)
J. Biol. Chem. 274, 25855-25861
   Abstract »    Full Text »    PDF »
Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
K. Friedrich, W. Kammer, I. Erhardt, S. Brandlein, W. Sebald, and R. Moriggl (1999)
Int. Immunol. 11, 1283-1294
   Abstract »    Full Text »    PDF »
One Lyn molecule is sufficient to initiate phosphorylation of aggregated high-affinity IgE receptors.
C. Wofsy, B. M. Vonakis, H. Metzger, and B. Goldstein (1999)
PNAS 96, 8615-8620
   Abstract »    Full Text »    PDF »
p70s6k Integrates Phosphatidylinositol 3-Kinase and Rapamycin-Regulated Signals for E2F Regulation in T Lymphocytes.
P. Brennan, J. W. Babbage, G. Thomas, and D. Cantrell (1999)
Mol. Cell. Biol. 19, 4729-4738
   Abstract »    Full Text »    PDF »
Interleukin-2 (IL-2) Regulates the Accessibility of the IL-2-Responsive Enhancer in the IL-2 Receptor alpha  Gene to Transcription Factors.
C. Rusterholz, P. C. Henrioud, and M. Nabholz (1999)
Mol. Cell. Biol. 19, 2681-2689
   Abstract »    Full Text »    PDF »
JAK3, STAT, and MAPK Signaling Pathways as Novel Molecular Targets for the Tyrphostin AG-490 Regulation of IL-2-Mediated T Cell Response.
L. H. Wang, R. A. Kirken, R. A. Erwin, C.-R. Yu, and W. L. Farrar (1999)
J. Immunol. 162, 3897-3904
   Abstract »    Full Text »    PDF »
Downregulation of JAK3 Protein Levels in T Lymphocytes by Prostaglandin E2 and Other Cyclic Adenosine Monophosphate-Elevating Agents: Impact on Interleukin-2 Receptor Signaling Pathway.
V. Kolenko, P. Rayman, B. Roy, M. K. Cathcart, J. O'Shea, R. Tubbs, L. Rybicki, R. Bukowski, and J. Finke (1999)
Blood 93, 2308-2318
   Abstract »    Full Text »    PDF »
IL-2-Mediated Cell Cycle Progression and Inhibition of Apoptosis Does Not Require NF-{kappa}B or Activating Protein-1 Activation in Primary Human T Cells.
M. Iacobelli, F. Rohwer, P. Shanahan, J. A. Quiroz, and K. L. McGuire (1999)
J. Immunol. 162, 3308-3315
   Abstract »    Full Text »    PDF »
Role of Interleukin (IL)-2 Receptor beta -Chain Subdomains and Shc in p38 Mitogen-activated Protein (MAP) Kinase and p54 MAP Kinase (Stress-activated Protein Kinase/c-Jun N-terminal Kinase) Activation. IL-2-DRIVEN PROLIFERATION IS INDEPENDENT OF p38 AND p54 MAP KINASE ACTIVATION.
A. E. Hunt, F. V. Lali, J. D. Lord, B. H. Nelson, T. Miyazaki, K. J. Tracey, and B. M. J. Foxwell (1999)
J. Biol. Chem. 274, 7591-7597
   Abstract »    Full Text »    PDF »
The Significance of Tetramerization in Promoter Recruitment by Stat5.
S. John, U. Vinkemeier, E. Soldaini, J. E. Darnell Jr., and W. J. Leonard (1999)
Mol. Cell. Biol. 19, 1910-1918
   Abstract »    Full Text »    PDF »
Thymic Stromal Lymphopoietin: A Cytokine That Promotes the Development of IgM+ B Cells In Vitro and Signals Via a Novel Mechanism.
S. D. Levin, R. M. Koelling, S. L. Friend, D. E. Isaksen, S. F. Ziegler, R. M. Perlmutter, and A. G. Farr (1999)
J. Immunol. 162, 677-683
   Abstract »    Full Text »    PDF »
IgE Hyperproduction Through Enhanced Tyrosine Phosphorylation of Janus Kinase 3 in NC/Nga Mice, a Model for Human Atopic Dermatitis.
M. Matsumoto, C. Ra, K. Kawamoto, H. Sato, A. Itakura, J. Sawada, H. Ushio, H. Suto, K. Mitsuishi, Y. Hikasa, et al. (1999)
J. Immunol. 162, 1056-1063
   Abstract »    Full Text »    PDF »
Functional Role of Interleukin-4 (IL-4) and IL-7 in the Development of X-Linked Severe Combined Immunodeficiency.
S. Kumaki, N. Ishii, M. Minegishi, S. Tsuchiya, D. Cosman, K. Sugamura, and T. Konno (1999)
Blood 93, 607-612
   Abstract »    Full Text »    PDF »
Signaling via the IL-2 and IL-7 Receptors from the Membrane to the Nucleus.
W.J. LEONARD, K. IMADA, H. NAKAJIMA, A. PUEL, E. SOLDAINI, and S. JOHN (1999)
Cold Spring Harb Symp Quant Biol 64, 417-424
   Abstract »    PDF »
Toxicologic Pathology of Cytokines, Cytokine Receptors, and Other Recombinant Human Proteins: Development of a Recombinant Interleukin-4-Pseudomonas Exotoxin for Therapy of Glioblastoma.
R. K. Puri (1999)
Toxicol Pathol 27, 53-57
   Abstract »    PDF »
Interleukin 7 Receptor Control of T Cell Receptor {gamma} Gene Rearrangement: Role of Receptor-associated Chains and Locus Accessibility.
S. K. Durum, S. Candeias, H. Nakajima, W. J. Leonard, A. M. Baird, L. J. Berg, and K. Muegge (1998)
J. Exp. Med. 188, 2233-2241
   Abstract »    Full Text »    PDF »
The Interleukin-4 Receptor Activates STAT5 by a Mechanism That Relies upon Common gamma -Chain.
A. Lischke, R. Moriggl, S. Brandlein, S. Berchtold, W. Kammer, W. Sebald, B. Groner, X. Liu, L. Hennighausen, and K. Friedrich (1998)
J. Biol. Chem. 273, 31222-31229
   Abstract »    Full Text »    PDF »
Interleukin 2-mediated Uncoupling of T Cell Receptor {alpha}/{beta} from CD3 Signaling.
L. Haughn, B. Leung, L. Boise, A. Veillette, C. Thompson, and M. Julius (1998)
J. Exp. Med. 188, 1575-1586
   Abstract »    Full Text »    PDF »
Functional Cooperation of the Interleukin-2 Receptor beta  Chain and Jak1 in Phosphatidylinositol 3-Kinase Recruitment and Phosphorylation.
T.-S. Migone, S. Rodig, N. A. Cacalano, M. Berg, R. D. Schreiber, and W. J. Leonard (1998)
Mol. Cell. Biol. 18, 6416-6422
   Abstract »    Full Text »
Role of Akt and c-Jun N-terminal Kinase 2 in Apoptosis Induced by Interleukin-4 Deprivation.
A. Cerezo, C. Martínez-A, D. Lanzarot, S. Fischer, T. F. Franke, and A. Rebollo (1998)
Mol. Biol. Cell 9, 3107-3118
   Abstract »    Full Text »
Molecular Mapping with Functional Antibodies Localizes Critical Sites on the Human IL Receptor Common {gamma} ({gamma}c) Chain.
N. Raskin, A. Jakubowski, I. Sizing, D. L. Olson, S. L. Kalled, C. A. Hession, C. D. Benjamin, D. P. Baker, and L. C. Burkly (1998)
J. Immunol. 161, 3474-3483
   Abstract »    Full Text »    PDF »
Activation of E2F-mediated Transcription by Human T-cell Leukemia Virus Type I Tax Protein in a p16INK4A-negative T-cell Line.
I. Lemasson, S. Thebault, C. Sardet, C. Devaux, and J.-M. Mesnard (1998)
J. Biol. Chem. 273, 23598-23604
   Abstract »    Full Text »    PDF »
Endocytosis of the Common Cytokine Receptor gamma c Chain. IDENTIFICATION OF SEQUENCES INVOLVED IN INTERNALIZATION AND DEGRADATION.
E. Morelon and A. Dautry-Varsat (1998)
J. Biol. Chem. 273, 22044-22051
   Abstract »    Full Text »    PDF »
Differential Regulation of the Janus Kinase-STAT Pathway and Biologic Function of IL-13 in Primary Human NK and T Cells: A Comparative Study with IL-4.
C.-R. Yu, R. A. Kirken, M. G. Malabarba, H. A. Young, and J. R. Ortaldo (1998)
J. Immunol. 161, 218-227
   Abstract »    Full Text »    PDF »
Cutting Edge: JAK3 Activation and Rescue of T Cells from HIV gp120-Induced Unresponsiveness.
N. Selliah and T. H. Finkel (1998)
J. Immunol. 160, 5697-5701
   Abstract »    Full Text »    PDF »
Interleukin-2 induces beta 2-integrin-dependent signal transduction involving the focal adhesion kinase-related protein B (fakB).
J. Brockdorff, S. B. Kanner, M. Nielsen, N. Borregaard, C. Geisler, A. Svejgaard, and N. Odum (1998)
PNAS 95, 6959-6964
   Abstract »    Full Text »    PDF »
Human and Simian T-Cell Leukemia Viruses Type 2 (HTLV-2 and STLV-2pan-p) Transform T Cells Independently of Jak/STAT Activation.
J. C. Mulloy, T.-S. Migone, T. M. Ross, N. Ton, P. L. Green, W. J. Leonard, and G. Franchini (1998)
J. Virol. 72, 4408-4412
   Abstract »    Full Text »    PDF »
Delineation of the Regions of Interleukin-2 (IL-2) Receptor beta  Chain Important for Association of Jak1 and Jak3. Jak1-INDEPENDENT FUNCTIONAL RECRUITMENT OF Jak3 TO IL-2Rbeta.
M.-h. Zhu, J. A. Berry, S. M. Russell, and W. J. Leonard (1998)
J. Biol. Chem. 273, 10719-10725
   Abstract »    Full Text »    PDF »
Regulation of Interleukin-13 Receptor Constituents on Mature Human B Lymphocytes.
H. Ogata, D. Ford, N. Kouttab, T. C. King, N. Vita, A. Minty, J. Stoeckler, D. Morgan, C. Girasole, J. W. Morgan, et al. (1998)
J. Biol. Chem. 273, 9864-9871
   Abstract »    Full Text »    PDF »
A Role for the Insulin-Interleukin (IL)-4 Receptor Motif of the IL-4 Receptor alpha -Chain in Regulating Activation of the Insulin Receptor Substrate 2 and Signal Transducer and Activator of Transcription 6 Pathways. ANALYSIS BY MUTAGENESIS.
H. Y. Wang, J. Zamorano, and A. D. Keegan (1998)
J. Biol. Chem. 273, 9898-9905
   Abstract »    Full Text »    PDF »
Involvement of the IL-2 Receptor {gamma}-Chain ({gamma}c) in the Control by IL-4 of Human Monocyte and Macrophage Proinflammatory Mediator Production.
C. S. Bonder, H. L. Dickensheets, J. J. Finlay-Jones, R. P. Donnelly, and P. H. Hart (1998)
J. Immunol. 160, 4048-4056
   Abstract »    Full Text »    PDF »
Heteromerization of the gamma c Chain with the Interleukin-9 Receptor alpha  Subunit Leads to STAT Activation and Prevention of Apoptosis.
J. H. Bauer, K. D. Liu, Y. You, S. Y. Lai, and M. A. Goldsmith (1998)
J. Biol. Chem. 273, 9255-9260
   Abstract »    Full Text »    PDF »
Stat Proteins Control Lymphocyte Proliferation by Regulating p27Kip1 Expression.
M. H. Kaplan, C. Daniel, U. Schindler, and M. J. Grusby (1998)
Mol. Cell. Biol. 18, 1996-2003
   Abstract »    Full Text »
Regulation of Cell Growth by IL-2: Role of STAT5 in Protection from Apoptosis But Not in Cell Cycle Progression.
J. Zamorano, H. Y. Wang, R. Wang, Y. Shi, G. D. Longmore, and A. D. Keegan (1998)
J. Immunol. 160, 3502-3512
   Abstract »    Full Text »    PDF »
Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells.
T.-S. Migone, N. A. Cacalano, N. Taylor, T. Yi, T. A. Waldmann, and J. A. Johnston (1998)
PNAS 95, 3845-3850
   Abstract »    Full Text »    PDF »
Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway.
T. Miyazaki, A. Takaoka, L. Nogueira, I. Dikic, H. Fujii, S. Tsujino, Y. Mitani, M. Maeda, J. Schlessinger, and T. Taniguchi (1998)
Genes & Dev. 12, 770-775
   Abstract »    Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)